Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

5 октября 2026 г. · показать заметки

Podcasts

ОБ ЭТОМ ЭПИЗОДЕ

Featuring an interview with Dr L Elizabeth Budde, including the following topics:

Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00)
Management of BsAb-induced cytokine release syndrome and other toxicities (7:35)
Use of BsAbs in the front-line treatment of diffuse large B-cell lymphoma (DLBCL); key findings from the Phase II MorningSun study (17:30)
Case: A man in his mid 50s with relapsed/refractory (R/R) DLBCL receives mosunetuzumab and polatuzumab vedotin in the second-line setting (23:18)
Case: A woman in her early 70s with R/R DLBCL receives glofitamab monotherapy in the third-line setting (32:52)
Case: A man in his early 80s with R/R DLBCL experiences disease progression after lisocabtagene maraleucel therapy, which was bridged with epcoritamab and gemcitabine/oxaliplatin (37:35)

CME information and select publications

Естественные науки

Медицина

английский

США

ИспользуйтеAPI, чтобы загрузить этот эпизод вJSON.

В ЭТОМ ЭПИЗОДЕ

lisocabtagene maraleucel

# polatuzumab vedotin

elizabeth budde

Изменить эти теги

ПОКАЗАТЬ ЗАМЕТКИ 🔗

00:00:00Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy

00:07:35Management of BsAb-induced cytokine release syndrome and other toxicities

00:17:30Use of BsAbs in the front-line treatment of diffuse large B-cell lymphoma (DLBCL); key findings from the Phase II MorningSun study

00:23:18Case: A man in his mid 50s with relapsed/refractory (R/R) DLBCL receives mosunetuzumab and polatuzumab vedotin in the second-line setting

00:32:52Case: A woman in her early 70s with R/R DLBCL receives glofitamab monotherapy in the third-line setting

00:37:35Case: A man in his early 80s with R/R DLBCL experiences disease progression after lisocabtagene maraleucel therapy, which was bridged with epcoritamab and gemcitabine/oxaliplatin

РАСШИФРОВКА 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

ПОИСК ПРОШЛЫХ ЭПИЗОДОВ

Искать прошлые эпизоды Hematologic Oncology Update.

Вставьте эту панель поиска на свой сайт

ДРУГИЕ ЭПИЗОДЫ В ЭТОМ ПОДКАсте

Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting

11 августа 2026 г.

Featuring perspectives from Prof Claire Harrison and Dr Raajit K Rampal, including the following topics: Introduction (0:00) The Biopathophysiology of Myelofibrosis (MF) (2:19) Current and Future Clinical Decision-Making in the Absence of Severe Cytopenias — Prof Harrison (7:49) Managing MF for Pa…

00:57:46

СОХРАНИТЬ

Клип

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

17 августа 2026 г.

Featuring perspectives from Dr Amrita Krishnan and Dr Robert Z Orlowski, including the following topics: Introduction (00:00) Up-Front Progression-Free Survival for Standard-Risk Disease — 2006, 2016 (1:47) Current and Emerging Therapeutic Approaches — Dr Orlowski (10:34) Chimeric Antigen Receptor…

00:57:45

СОХРАНИТЬ

Клип

$Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program$

Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program

2 сентября 2026 г.

Featuring perspectives from Dr William G Wierda, including the following topics: Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00) Sequencing Road Map (12:39) Key Datasets — Pirtobrutinib (21:08) Investigator Survey (34:09) Chimeric Antigen Receptor T-Cell T…

00:58:40

СОХРАНИТЬ

Клип

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

26 августа 2026 г.

Featuring perspectives from Dr Matthew Matasar and Dr Sonali M Smith, including the following topics: Introduction: Lymphoma Survivorship (0:00) Novel Treatment Approaches for Diffuse Large B-Cell Lymphoma — Dr Matasar (6:49) Novel Treatment Approaches for Follicular Lymphoma and Mantle Cell Lymph…

01:00:04

СОХРАНИТЬ

Клип

Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies

13 августа 2026 г.

Featuring perspectives from Dr Jeremy S Abramson, Dr Joshua Brody, Dr Manali Kamdar, Dr Tycel Phillips and Dr Jason Westin, moderated by Dr Abramson, including the following topics: Introduction (0:00) Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Ka…

01:59:30

СОХРАНИТЬ

Клип

Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из Dr. Neil Love, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.